Can AI Cure Disease?

In this episode of Data Analytics Chat, we discuss the impact of AI on clinical research. Ben Gmeiner, Director of Medical Data Strategy and Science at Novartis, a global pharmaceutical organisation, joins us. We discuss AI's massive potential to revolutionise healthcare, enhance precision medicine, and improve clinical trials. Ben highlights the importance of integrating AI smoothly into existing workflows, ensuring data privacy, and overcoming regulatory challenges. We explore how AI can boost patient engagement and trial adherence and overcome the biggest barriers.00:00 Introduction to Data Analytics Chat00:30 Meet Ben Gmeiner, Director of Medical Data Strategy at Novartis01:51 The Explosion of Health Data02:45 AI's Transformative Impact on Clinical Research04:13 Advancements in Clinical Trials with AI10:23 Leveraging Health Data for AI Solutions14:31 Challenges in AI Adoption in Healthcare25:56 Regulatory Environment and AI Integration31:39 Improving Patient Engagement with AI34:04 Conclusion and Final ThoughtsThank you for listening!

There are no comments yet.

Please log in to write the first comment.